newsfilter
← Latest News
PR Newswire·

Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment

Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company has received a Notice of...